[1]
J. Robinson and I. Banerjee, “Monoclonal Antibody Cocktail therapy for COVID-19: A Pharmacological innovation”, J Adv Intern Med, vol. 10, no. 2, pp. 103–105, Dec. 2021, doi: 10.3126/jaim.v10i2.42200.